Your browser doesn't support javascript.
loading
SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.
van den Boorn, Héctor G; Abu-Hanna, Ameen; Ter Veer, Emil; van Kleef, Jessy Joy; Lordick, Florian; Stahl, Michael; Ajani, Jaffer A; Guimbaud, Rosine; Park, Se Hoon; Dutton, Susan J; Bang, Yung-Jue; Boku, Narikazu; Mohammad, Nadia Haj; Sprangers, Mirjam A G; Verhoeven, Rob H A; Zwinderman, Aeilko H; van Oijen, Martijn G H; van Laarhoven, Hanneke W M.
Afiliação
  • van den Boorn HG; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. h.vanlaarhoven@amc.uva.nl.
  • Abu-Hanna A; Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. a.abu-hanna@amc.uva.nl.
  • Ter Veer E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. e.terveer@amc.uva.nl.
  • van Kleef JJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. j.j.vankleef@amc.uva.nl.
  • Lordick F; 1st Medical Department, University Cancer Center Leipzig (UCCL), University Hospital Leipzig, 04103 Leipzig, Germany. florian.lordick@medizin.uni-leipzig.de.
  • Stahl M; Department of Medical Oncology and Hematology, Kliniken Essen-Mitte, 45136 Essen, Germany. m.stahl@kliniken-essen-mitte.de.
  • Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA. jajani@mdanderson.org.
  • Guimbaud R; Department of Medical Oncology, Centre Hospitalo-Univeristaire de Toulouse, 31400 Toulouse, France. guimbaud.r@chu-toulouse.fr.
  • Park SH; University School of Medicine, Samsung Medical Center, Sungkyunkwan, 06351 Seoul, Korea. hematoma@skku.edu.
  • Dutton SJ; Oxford Clinical Trials Research Unit and Centre for Statistics in Medicine, University of Oxford, OX1 2JD Oxford, UK. susan.dutton@csm.ox.ac.uk.
  • Bang YJ; Seoul National University College of Medicine, Seoul National University Hospital, 03080 Seoul, Korea. bangyj@snu.ac.kr.
  • Boku N; Department of Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 104-0045 Tokyo, Japan. nboku@ncc.go.jp.
  • Mohammad NH; Department of Medical Oncology, UMC Utrecht, 3584 CX Utrecht, Utrecht University, The Netherlands. n.hajmohammad@umcutrecht.nl.
  • Sprangers MAG; Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. m.a.sprangers@amc.uva.nl.
  • Verhoeven RHA; Netherlands Comprehensive Cancer Organization (IKNL), 5612 HZ Eindhoven, The Netherlands. r.verhoeven@iknl.nl.
  • Zwinderman AH; Department of Surgery, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands. r.verhoeven@iknl.nl.
  • van Oijen MGH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. a.h.zwinderman@amc.uva.nl.
  • van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. m.g.vanoijen@amc.uva.nl.
Cancers (Basel) ; 11(2)2019 Feb 05.
Article em En | MEDLINE | ID: mdl-30764578
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda